Metallo-b-lactamases (MBLs) are di-Zn(II) metalloenzymes that e‹ciently hydrolyze most b-lactam antibiotics used in clinical settings. Bacteria producing MBLs have been isolated from clinical settings and from natural environments such as rivers and soils, and are now recognized as a new potential threat to human health. No eŠective inhibitors are available for clinical use, making the treatment of infectious diseases caused by bacteria producing MBLs more di‹cult. IMP-1 is encoded on a plasmid which can be horizontally transferred between bacterial strains. Our studies on MBLs, and especially on IMP-1, focus on understanding the role of Zn(II) ion(s) in the hydrolysis of b-lactam antibiotics and on the detailed structure of the IMP-1 active site in order to develop e‹cient inhibitors. We investigated the role of the two Zn(II) ions in IMP-1 by kinetic, spectroscopic and thermodynamic analyses. The results revealed that theˆrst Zn(II) ion is necessary for the hydrolysis of b-lactam antibiotics while the second Zn(II) ion enhances enzyme activity and structural stability, thus helping the enzyme achieve maximum activity. The detailed structures of the IMP-1 active site were examined by X-ray crystallography. Thiol compounds for irreversibly inhibiting IMP-1 were developed and the binding mode of these inhibitors was investigated in detail. Theseˆndings will aid the design of inhibitors that target MBLs. 
The residues are labeled according to BBL standard numbering. 4) Zn1 is coordinated by His116, His118 and His196, which constitute the`3H site' or the`Zn1 site'. Zn2 is coordinated by Asp120, Cys221, His263, and a water molecule (the apical water), which constitute the`DCH site' or the`Zn2 site'. Theˆgure was prepared using PyMol software (http://pymol.sourceforgen.net/). 
Cys, His で構成されている（DCH サイト又は Zn2 The solid line was generated by nonlinear least-squaresˆtting of the experimental data to the following equation:
where k f and k s are the rate constants for the fast and slow inactivation reactions, respectively, and a is the ratio of the activity of mono-Zn IMP-1 to that of di-Zn IMP-1. Reprinted with permission from (Yamaguchi Y. et al. ChemBioChem, 12, 1979 1983 
